Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2014

Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Chronic Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2014.

Monthly Oil & Gas Industry Contracts Review: The EMEA Region Leads Award Activity

Monthly Oil & Gas Industry Contracts Review: The EMEA Region Leads Award Activity is a new market research publication announced by Reportstack. The report is an essential source of data on the contracts and open tenders in the oil and gas industry. The report portrays detailed comparative data on the number of contracts and their value in the month, subdivided by region, sector and geographies in May 2014. Additionally, the report provides information on the top contractors and issuers based on the worth of contracts executed in the oil and gas industry during the month by geographies and over the year.

Scope

- Analyze oil and gas contracts and open tenders in the global arena
- Review of contracts/open tenders in the upstream sector - exploration and production, midstream sector - pipeline, transportation, storage and processing, and in the downstream sector - refining and marketing
- Information on the top awarded contracts by sector that took place in the oil and gas industry
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa
- Summary of top contractors in the oil and gas industry in YTD 2014 subdivided by the sector. This includes key contractors such as SK Engineering & Construction, Saipem Azfen JV, Technip, GS Holdings, Chicago Bridge & Iron Company and Punj Lloyd
- Summary of top issuers in the oil and gas industry in YTD 2014 subdivided by the sector. This includes key issuers such as Total, Eni, BP, Kuwait National Petroleum Company (KNPC) and Ecopetrol

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major contracts/ open tenders focused sectors for investments in your industry.
- Understand the contracts and open tenders activity in the oil and gas industry
- Evaluate the type of services offered by key contractors during the month.
- Identify growth sectors and regions wherein contracts opportunities are more lucrative.
- Look for key contractors/issuers if you are looking to award a contract or interested in open tender activity within the oil and gas industry.

To view the table of contents and know more details please visit  Monthly Oil & Gas Industry Contracts Review: The EMEA Region Leads Award Activity.

2013 Global Biopower Market - Supply Chain Bottlenecks Leave the Market Downcast

2013 Global Biopower Market - Supply Chain Bottlenecks Leave the Market Downcast is a new market research publication announced by Reportstack. The global biopower market recorded a total installed capacity of 84,256 MW by the year end 2013. The key countries which include, the US, Brazil, Germany, China and India occupied more than half of the (around 55%) of the global biopower market in the year 2013. The biopower market is expected to witness a decline in annual capacity for the year 2014. This can be majorly attributed to the supply chain bottlenecks prevailing in the biopower industry coupled with some radical changes in the policy framework of a few of the biopower markets.

Scope

- The report focuses on the biopower market scenario in the year 2013 and provides the outlook for the year 2014.
- It provides detailed analysis on the biopower market of the leading countries across the globe.
- It includes information on cumulative installed biopower capacity by feedstock for key countries.
- The report also throws light on the key issues hampering the growth of some of the leading countries.
- The scope encompasses LCOE analysis on global biomass market.

Reasons to buy

- It enables to comprehend the global biopower market in 2013 and also envisions the market outlook for the year 2014.
- Comprehensive analysis on the biopower market of the key countries makes this report an evident choice for the readers.
- It also highlights the key issues impacting the growth of the leading biopower nations
- The report provides statistics on the biopower capacity by feedstock for major countries. This information is very valuable, insightful and a rare content available in the market
- LCOE analysis on biomass market adds value to the report

To view the table of contents and know more details please visit 2013 Global Biopower Market - Supply Chain Bottlenecks Leave the Market Downcast.

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018 is a new market research publication announced by Reportstack. Amyotrophic lateral sclerosis (ALS) is a rare, but fatal, motor neuron disease (MND) characterized by axonal degeneration and progressive loss of motor neurons. ALS affects both the upper (brain to spinal cord) and lower (brain stem to muscle tissue) motor neurons, gradually reducing a patient’s ability to initiate and control muscle movement. Muscle atrophy, starting in the periphery (arms and legs), ultimately leads to complete paralysis after several years of progressive worsening of muscle strength. Respiratory failure is the most common cause of death, as smooth muscle function becomes affected when the disease is in its final stages. The progressively degenerative course of the condition is a great burden for both patients and caregivers, as well as for society. ALS usually affects people age =40 years, and has a worldwide incidence of about two cases per 100,000 population, and a prevalence ranging between four and seven cases per 100,000.

Key Questions Answered

- How does the patent expiration of Rilutek effect the ALS market?
- The pipeline consists of novel but unproven mechanisms of action in ALS. Which of these therapies will attain high sales revenues during 2013-2018, and in which markets?
- How large an impact will Methycobal and Edaravone have on the ALS market in Japan? What do key opinion leaders think of these treatment approaches?
- What effects will advancing diagnostic and disease modeling capabilities have on drug development?
- What regulatory efforts are likely to affect drug development in the markets researched? Which is the largest growth market globally?

Key Findings

- Country-specific orphan drug and rare disease policy heavily influences development opportunities in the 7MM.
- Discovery of potential symptomatic and disease-modifying therapies in early stage clinical development is challenged by the absence of ALS biomarkers and disease staging that can demonstrate a patient’s response to treatment.
- Pharmaceutical products for ALS will face growing competition from gene and stem cell-based therapies.
- Advances in animal modeling are expected to have a significant impact on ALS drug development.

Scope

- Overview of ALS, including etiology and pathophysiology, general symptoms, quality of life, country-specific treatment recommendations and epidemiologic data.
- Annualized ALS market revenue, annual cost of treatment and usage patterns from 2013 and forecast for five years to 2018.
- Key topics covered include unmet needs analysis, research and development strategies, pipeline assessment, and pipeline valuation analysis for the ALS market.
- Pipeline valuation analysis: clinical and commercial benchmarking of AB Science’s AB-1010 (masitinib), Cytokinetics’ CK-2017357 (tirasemtiv), Mitsubishi Tanabe’s Radicut (edaravone), Eisai’s Methycobal (mecobalamin), and Orphazyme ApS’ arimoclomol.
- Assessment of the current and future market competition in the global ALS drug market. Insightful review of the key industry and governmental drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the ALS market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global ALS market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global ALS market from 2013-2018.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

To view the table of contents and know more details please visit  OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018.

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Bipolar Disorder (Manic Depression) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bipolar Disorder (Manic Depression). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bipolar Disorder (Manic Depression). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014.

Chronic Pancreatitis Pain Global Clinical Trials Review, H1, 2014

Chronic Pancreatitis Pain Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Chronic Pancreatitis Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Pancreatitis Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Pancreatitis Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Chronic Pancreatitis Pain Global Clinical Trials Review, H1, 2014.

Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014

Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Chronic Subdural Hematoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Subdural Hematoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Subdural Hematoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014.

Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014

Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Cognitive Impairment Associated With Schizophrenia (CIAS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cognitive Impairment Associated With Schizophrenia (CIAS). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cognitive Impairment Associated With Schizophrenia (CIAS). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014.

Cognitive Impairment Global Clinical Trials Review, H1, 2014

Cognitive Impairment Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Cognitive Impairment clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cognitive Impairment. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit  Cognitive Impairment Global Clinical Trials Review, H1, 2014.

Convulsions Global Clinical Trials Review, H1, 2014

Convulsions Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Convulsions clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Convulsions. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Convulsions. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Convulsions Global Clinical Trials Review, H1, 2014.

Degenerative Scoliosis Global Clinical Trials Review, H1, 2014

Degenerative Scoliosis Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Degenerative Scoliosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Degenerative Scoliosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Degenerative Scoliosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Degenerative Scoliosis Global Clinical Trials Review, H1, 2014.

Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014

Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Degenerative Spondylolisthesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Degenerative Spondylolisthesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Degenerative Spondylolisthesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014.

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Dysgeusia (Taste Disorders) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysgeusia (Taste Disorders). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dysgeusia (Taste Disorders). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014.

Fibromyalgia Global Clinical Trials Review, H1, 2014

Fibromyalgia Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Fibromyalgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fibromyalgia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fibromyalgia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Fibromyalgia Global Clinical Trials Review, H1, 2014.

Paralysis Global Clinical Trials Review, H1, 2014

Paralysis Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Paralysis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Paralysis Global Clinical Trials Review, H1, 2014.

Restless Legs Syndrome Global Clinical Trials Review, H1, 2014

Restless Legs Syndrome Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Restless Legs Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Restless Legs Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Restless Legs Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Restless Legs Syndrome Global Clinical Trials Review, H1, 2014.

Dementia Associated With Alzheimer’s Disease Global Clinical Trials Review, H1, 2014

Dementia Associated With Alzheimer’s Disease Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report  provides data on the Dementia Associated With Alzheimer’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dementia Associated With Alzheimer’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dementia Associated With Alzheimer’s Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Dementia Associated With Alzheimer’s Disease Global Clinical Trials Review, H1, 2014.

Drug Addiction Global Clinical Trials Review, H1, 2014

Drug Addiction Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Drug Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Drug Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Drug Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Drug Addiction Global Clinical Trials Review, H1, 2014.

Hemiplegia Global Clinical Trials Review, H1, 2014

Hemiplegia Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report  provides data on the Hemiplegia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemiplegia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemiplegia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Hemiplegia Global Clinical Trials Review, H1, 2014.

Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014

Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the Mild Cognitive Impairment clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mild Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mild Cognitive Impairment. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To view the table of contents and know more details please visit Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014.

China Animal Vaccine Industry Report, 2013-2016

China Animal Vaccine Industry Report, 2013-2016 is a new market research publication announced by Reportstack. Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main force of traditional animal vaccine markets in the world, still taking around 60% nowadays. In recent years, European and American animal vaccine markets have decelerated growth due to quality safety, high maturity and other factors, while the fast-growing animal vaccine market of China and other emerging countries will become a new highlight.

In 2004-2013, Chinese animal vaccine market size maintained a high growth rate of 26.3%, reaching about RMB11.5 billion in 2013. The growth in 2007-2010 was mainly driven by the expansion of governmental tender vaccine, while that from 2011 was primarily thanks to the market-oriented vaccine expansion. The Chinese animal vaccine market is basically occupied by local companies, showing a self-sufficiency rate of around 90%.

Given the policy factor, Chinese animal vaccine products are divided into compulsory immunization vaccines and market-oriented vaccines. At present, the former include foot-and-mouth disease (FMD), bird flu, porcine reproductive and respiratory syndrome (PRRS), swine fever, and peste des petits ruminants (PPR); the latter refer to porcine circovirus (PCV), Newcastle disease, porcine parvovirus (PPV) and other varieties. Since 2011, the bids for compulsory vaccines proposed by the Chinese government has turned to be more fierce, with limited growth potential; however, market-oriented vaccines have developed faster, enjoying 40%-50% market share in 2013.

According to animal attributes, animal vaccines can be classified into swine vaccines, poultry vaccines, cattle & sheep vaccines, pet vaccines and other vaccines. In 2013, Chinese swine vaccines and poultry vaccines accounted for more than 80% of the animal vaccine market. In addition, the emerging Chinese pet industry is boosting the demand for pet vaccines, but due to lack of commercialized pet vaccines, China now mainly relies on imports. Thus, the Chinese pet vaccine market will see a larger space for development in the future.

As the scale of Chinese farming escalates, the demand for animal vaccines will continue to grow steadily. In the next few years, the Chinese animal vaccine industry is expected to keep a growth rate of approximately 15% and see market value of RMB17.5 billion or so in 2016.

In 2006, China implemented mandatory veterinary drug GMP certification to raise the threshold, resulting in a sharp decline in the number of animal vaccine companies and the accompanying increased industry concentration. In 2013, CAHIC seized the highest market share of 10.5% among Chinese listed animal vaccine companies, followed by Jinyu Group, Tecon and Dahuanong with a combined proportion of 15% or so.


China Animal Vaccine Industry Report, 2013-2016 by ResearchInChina covers the followings: 
-The market size, market structure and competitive landscape of the global animal vaccine industry;
-The market size, market structure, competitive landscape and import & export of the Chinese animal vaccine industry; 
-Policies, social environment and downstream demand of the Chinese animal vaccine industry;
-The size and competitive landscape of Chinese animal vaccine market segments such as swine vaccines and poultry vaccines;
-Operation, animal vaccine business, forecast and outlook of 10 Chinese animal vaccine manufacturers;
-The market size and market structure of Chinese animal vaccine market and its segments in 2013-2016E.

Companies Mentioned

CAHIC , Jinyu Group, Tecon, Tech-bank , Shenghua Biok, Ringpu Bio-technology, Dahuanong, Hile Bio , Yikang, Chopper

     

To view the table of contents and know more details please visit China Animal Vaccine Industry Report, 2013-2016.

2014 Market Research Report on Global Plasma Melting Tank Industry

2014 Market Research Report on Global Plasma Melting Tank Industry is a new market research publication announced by Reportstack. This was a professional and depth research report on Global Plasma Melting Tank industry that you would know the world's major regional market conditions of Plasma Melting Tank industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.

The report firstly introduced Plasma Melting Tank basic information including Plasma Melting Tank definition classification application and industry chain overview; Plasma Melting Tank industry policy and plan, Plasma Melting Tank product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.

In the end, the report introduced Plasma Melting Tank new project SWOT analysis, investment feasibility analysis, and investment return analysis and Global Plasma Melting Tank industry.

In a word, it was a depth research report on Global Plasma Melting Tank industry. And thanks to the support and assistance from Plasma Melting Tank industry chain related technical experts and marketing experts during Research Team survey and interviews.

The report including six parts, the first part maainly introduced the product basic information; the second parts mainly analyzed the Asia Plasma Melting Tank industry; the third part mainly analyzed the North American Plasma Melting Tank industry; the fourth part mainly analyzed the Europe Plasma Melting Tank industry; the fifth part mainly analyzed the market entry and investment feasibility; the sixth part was the report conclusion chapter.

To view the table of contents and know more details please visit 2014 Market Research Report on Global Plasma Melting Tank Industry.

2014 Market Research Report on Global Sodium Chloride Injection Industry

2014 Market Research Report on Global Sodium Chloride Injection Industry is a new market research publication announced by Reportstack. This was a professional and depth research report on Global Sodium Chloride Injection industry that you would know the world's major regional market conditions of Sodium Chloride Injection industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.

The report firstly introduced Sodium Chloride Injection basic information including Sodium Chloride Injection definition classification application and industry chain overview; Sodium Chloride Injection industry policy and plan, Sodium Chloride Injection product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.

In the end, the report introduced Sodium Chloride Injection new project SWOT analysis, investment feasibility analysis, and investment return analysis and Global Sodium Chloride Injection industry. In a word, it was a depth research report on Global Sodium Chloride Injection industry. And thanks to the support and assistance from Sodium Chloride Injection industry chain related technical experts and marketing experts during Research Team survey and interviews.

The report including six parts, the first part maainly introduced the product basic information; the second parts mainly analyzed the Asia Sodium Chloride Injection industry; the third part mainly analyzed the North American Sodium Chloride Injection industry; the fourth part mainly analyzed the Europe Sodium Chloride Injection industry; the fifth part mainly analyzed the market entry and investment feasibility; the sixth part was the report conclusion chapter.

To view the table of contents and know more details please visit 2014 Market Research Report on Global Sodium Chloride Injection Industry.

2014 Market Research Report on Global Blood Cell Separator Industry

2014 Market Research Report on Global Blood Cell Separator Industry is a new market research publication announced by Reportstack. This was a professional and depth research report on Global Blood Cell Separator industry that you would know the world's major regional market conditions of Blood Cell Separator industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.

The report firstly introduced Blood Cell Separator basic information including Blood Cell Separator definition classification application and industry chain overview; Blood Cell Separator industry policy and plan, Blood Cell Separator product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.

In the end, the report introduced Blood Cell Separator new project SWOT analysis, investment feasibility analysis, and investment return analysis and Global Blood Cell Separator industry.

In a word, it was a depth research report on Global Blood Cell Separator industry. And thanks to the support and assistance from Blood Cell Separator industry chain related technical experts and marketing experts during Research Team survey and interviews.

The report including six parts, the first part maainly introduced the product basic information; the second parts mainly analyzed the Asia Blood Cell Separator industry; the third part mainly analyzed the North American Blood Cell Separator industry; the fourth part mainly analyzed the Europe Blood Cell Separator industry; the fifth part mainly analyzed the market entry and investment feasibility; the sixth part was the report conclusion chapter.

To view the table of contents and know more details please visit 2014 Market Research Report on Global Blood Cell Separator Industry.

2014 Market Research Report on Global Ethylene Oxide Sterilizers Industry

2014 Market Research Report on Global Ethylene Oxide Sterilizers Industry is a new market research publication announced by Reportstack. This was a professional and depth research report on Global Ethylene Oxide Sterilizers industry that you would know the world's major regional market conditions of Ethylene Oxide Sterilizers industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.

The report firstly introduced Ethylene Oxide Sterilizers basic information including Ethylene Oxide Sterilizers definition classification application and industry chain overview; Ethylene Oxide Sterilizers industry policy and plan, Ethylene Oxide Sterilizers product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.

In the end, the report introduced Ethylene Oxide Sterilizers new project SWOT analysis, investment feasibility analysis, and investment return analysis and Global Ethylene Oxide Sterilizers industry.

In a word, it was a depth research report on Global Ethylene Oxide Sterilizers industry. And thanks to the support and assistance from Ethylene Oxide Sterilizers industry chain related technical experts and marketing experts during Research Team survey and interviews.

The report including six parts, the first part maainly introduced the product basic information; the second parts mainly analyzed the Asia Ethylene Oxide Sterilizers industry; the third part mainly analyzed the North American Ethylene Oxide Sterilizers industry; the fourth part mainly analyzed the Europe Ethylene Oxide Sterilizers industry; the fifth part mainly analyzed the market entry and investment feasibility; the sixth part was the report conclusion chapter.

To view the table of contents and know more details please visit  2014 Market Research Report on Global Ethylene Oxide Sterilizers Industry.